Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Differential effects of interferon-β1b on cytokine patterns of CD4+ and CD8+ T cells derived from RRMS and PPMS patients.
Risk alleles for multiple sclerosis identified by a genomewide study.
Episode 60 with Dr. Timothy Vollmer on early, highly effective treatment
Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis.
ACTRIMS-ECTRIMS 2014 -- Day 3, afternoon
The complex role of estrogens in inflammation.
ACTRIMS-ECTRIMS 2014 -- Day 2, afternoon
BG 12: BG 00012, BG 12/Oral Fumarate, FAG-201, second-generation fumarate derivative--Fumapharm/Biogen Idec.
Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice.
Prevention and Mitigation of Experimental Autoimmune Encephalomyelitis by Murine β-Defensins via Induction of Regulatory T Cells.
Episode 62 with Dr. Ellen Mowry on vitamin D and caloric restriction for MS
Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)
Episode 48 with Dr. Bruce Cree on the EPIC, CLIMB, and SUMMIT clinical studies
Safety Study of Combination Therapy with Intramuscular Avonex and Oral CellCept in Patients with Multiple Sclerosis
Episode 52 with Dr. David Tabby on migraines in MS
ACTRIMS-ECTRIMS 2014 -- Day 2, morning
MS Research Roundup: July 17, 2014
Early magnetic resonance imaging predictors of clinical progression after 48 months in clinically isolated syndrome patients treated with intramuscular interferon β-1a.
Mycophenolate mofetil in multiple sclerosis: a multicentre retrospective study on 344 patients.
Episode 46 with Dr. Hans Lassmann on biomarkers in NMO and MS
IFN-β Treatment Requires B Cells for Efficacy in Neuroautoimmunity.
Brain MRI results of DECIDE: a randomized, double-blind trial of DAC HYP vs. IFNβ-1a in RRMS patients
A timing-of-birth effect on multiple sclerosis clinical phenotype.
Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study.
Comparative pharmacogenetics of multiple sclerosis: IFN-β versus glatiramer acetate.

Pages